Infection in the pathogenesis and course of chronic obstructive pulmonary disease.

By S. Sethi, T. Murphy. New England Journal of Medicine, 2008

1,251 citations recorded by the source corpus.

Subfields: Emergency Medical Services, Epidemiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/2c5ff6b0fd025c6bd4eaf66cd0587c96db10606a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Emergency Medical Services

1. P. Barnes
2. G. Hajishengallis

In Epidemiology

1. G. Hajishengallis

In Pulmonary and Respiratory Medicine

1. P. Barnes
2. R. Rodríguez-Roisín
3. C. Jenkins
4. Sonia Buist
5. Jan Zieliński
6. Yoshinosuke Fukuchi
7. S. Hurd
8. A. Anzueto

Citations in the corpus

• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “Haemophilus influenzae, Streptococcus pneumoniae, andMoraxella catarrhalis are the most common bacterial pathogens involved in an exacerbation (108); in GOLD 3 and GOLD 4 patients, Pseudomonas aeruginosa becomes important.”
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Наиболее распро" страненными возбудителями при обострениях ХОБЛ являются Haemophilus influenzae, Streptococcus pneu moniae и Moraxella catarrhalis [409].”
• Periodontitis: from microbial immune subversion to systemic inflammation (2014, background): “Polymicrobial infections including the opportunistic pathogen Pseudomonas aeruginosa are associated with exacerbations of COPD increasing its morbidity and mortality 23,146 .”
• Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. (2012, neutral): “5) CRP, mg/L 3 (2) 24 (67) 3 (7) 3 (5)”